TY - STD TI - Psoriasis: More Than Cosmetic[http://www.fda.gov/fdac/features/2004/504_psoriasis.html] UR - http://www.fda.gov/fdac/features/2004/504_psoriasis.html ID - ref1 ER - TY - JOUR AU - de Arruda, L. H. AU - De Moraes, A. P. PY - 2001 DA - 2001// TI - The impact of psoriasis on quality of life JO - Br J Dermatol VL - 144 UR - https://doi.org/10.1046/j.1365-2133.2001.144s58033.x DO - 10.1046/j.1365-2133.2001.144s58033.x ID - de Arruda2001 ER - TY - JOUR AU - Finlay, A. Y. PY - 1998 DA - 1998// TI - Quality of life assessments in dermatology JO - Semin Cutan Med Surg VL - 17 UR - https://doi.org/10.1016/S1085-5629(98)80026-6 DO - 10.1016/S1085-5629(98)80026-6 ID - Finlay1998 ER - TY - JOUR AU - Rapp, S. R. AU - Cottrell, C. A. AU - Leary, M. R. PY - 2001 DA - 2001// TI - Social coping strategies associated with quality of life decrements among psoriasis patients JO - Br J Dermatol VL - 145 UR - https://doi.org/10.1046/j.1365-2133.2001.04444.x DO - 10.1046/j.1365-2133.2001.04444.x ID - Rapp2001 ER - TY - JOUR AU - Rapp, S. R. AU - Feldman, S. R. AU - Exum, M. L. AU - Fleischer, A. B. AU - Reboussin, D. M. PY - 1999 DA - 1999// TI - Psoriasis causes as much disability as other major medical diseases JO - J Am Acad Dermatol VL - 41 UR - https://doi.org/10.1016/S0190-9622(99)70112-X DO - 10.1016/S0190-9622(99)70112-X ID - Rapp1999 ER - TY - JOUR AU - Wahl, A. PY - 1997 DA - 1997// TI - The impact of psoriasis on psychosocial life domains. A review JO - Scand J Caring Sci VL - 11 UR - https://doi.org/10.1111/j.1471-6712.1997.tb00463.x DO - 10.1111/j.1471-6712.1997.tb00463.x ID - Wahl1997 ER - TY - JOUR AU - Weiss, S. C. AU - Kimball, A. B. AU - Liewehr, D. J. AU - Blauvelt, A. AU - Turner, M. L. AU - Emanuel, E. J. PY - 2002 DA - 2002// TI - Quantifying the harmful effect of psoriasis on health-related quality of life JO - J Am Acad Dermatol VL - 47 UR - https://doi.org/10.1067/mjd.2002.122755 DO - 10.1067/mjd.2002.122755 ID - Weiss2002 ER - TY - JOUR AU - Krueger, G. AU - Koo, J. AU - Lebwohl, M. AU - Menter, A. AU - Stern, R. S. AU - Rolstad, T. PY - 2001 DA - 2001// TI - The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey JO - Arch Dermatol VL - 137 ID - Krueger2001 ER - TY - JOUR AU - Krueger, G. G. AU - Feldman, S. R. AU - Camisa, C. AU - Duvic, M. AU - Elder, J. T. AU - Gottlieb, A. B. AU - Koo, J. AU - Krueger, J. G. AU - Lebwohl, M. AU - Lowe, N. AU - Menter, A. AU - Morison, W. L. AU - Prystowsky, J. H. AU - Shupack, J. L. AU - Taylor, J. R. AU - Weinstein, G. D. AU - Barton, T. L. AU - Rolstad, T. AU - Day, R. M. PY - 2000 DA - 2000// TI - Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis? JO - J Am Acad Dermatol VL - 43 UR - https://doi.org/10.1067/mjd.2000.106374 DO - 10.1067/mjd.2000.106374 ID - Krueger2000 ER - TY - JOUR AU - Finlay, A. Y. AU - Salek, M. S. AU - Haney, J. PY - 2003 DA - 2003// TI - Intramuscular alefacept improves health-related quality of life in patients with chronic plaque psoriasis JO - Dermatology VL - 206 UR - https://doi.org/10.1159/000069942 DO - 10.1159/000069942 ID - Finlay2003 ER - TY - JOUR AU - Gordon, K. B. AU - Papp, K. A. AU - Hamilton, T. K. AU - Walicke, P. A. AU - Dummer, W. AU - Li, N. AU - Bresnahan, B. W. AU - Menter, A. PY - 2003 DA - 2003// TI - Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial JO - JAMA VL - 290 UR - https://doi.org/10.1001/jama.290.23.3073 DO - 10.1001/jama.290.23.3073 ID - Gordon2003 ER - TY - JOUR AU - Gottlieb, A. B. AU - Matheson, R. T. AU - Lowe, N. AU - Krueger, G. G. AU - Kang, S. AU - Goffe, B. S. AU - Gaspari, A. A. AU - Ling, M. AU - Weinstein, G. D. AU - Nayak, A. AU - Gordon, K. B. AU - Zitnik, R. PY - 2003 DA - 2003// TI - A randomized trial of etanercept as monotherapy for psoriasis JO - Arch Dermatol VL - 139 UR - https://doi.org/10.1001/archderm.139.12.1627 DO - 10.1001/archderm.139.12.1627 ID - Gottlieb2003 ER - TY - JOUR AU - Leonardi, C. L. AU - Powers, J. L. AU - Matheson, R. T. AU - Goffe, B. S. AU - Zitnik, R. AU - Wang, A. AU - Gottlieb, A. B. PY - 2003 DA - 2003// TI - Etanercept as monotherapy in patients with psoriasis JO - N Engl J Med VL - 349 UR - https://doi.org/10.1056/NEJMoa030409 DO - 10.1056/NEJMoa030409 ID - Leonardi2003 ER - TY - JOUR AU - Reich, K. AU - Nestle, F. O. AU - Papp, K. AU - Ortonne, J. P. AU - Wu, Y. AU - Bala, M. AU - Evans, R. AU - Guzzo, C. AU - Li, S. AU - Dooley, L. T. AU - Griffiths, C. E. PY - 2006 DA - 2006// TI - Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial JO - Br J Dermatol VL - 154 UR - https://doi.org/10.1111/j.1365-2133.2006.07237.x DO - 10.1111/j.1365-2133.2006.07237.x ID - Reich2006 ER - TY - JOUR AU - Krueger, G. G. AU - Langley, R. G. AU - Finlay, A. Y. AU - Griffiths, C. E. AU - Woolley, J. M. AU - Lalla, D. AU - Jahreish, A. PY - 2005 DA - 2005// TI - Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial JO - Br J Dermatol VL - 153 UR - https://doi.org/10.1111/j.1365-2133.2005.06948.x DO - 10.1111/j.1365-2133.2005.06948.x ID - Krueger2005 ER - TY - JOUR AU - Revicki, D. AU - Willian, M. K. AU - Saurat, J. H. AU - Papp, K. A. AU - Ortonne, J. P. AU - Sexton, C. AU - Camez, A. PY - 2008 DA - 2008// TI - Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week clinical trial in patients with moderate to severe plaque psoriasis JO - Br J Dermatol VL - 158 UR - https://doi.org/10.1111/j.1365-2133.2007.08236.x DO - 10.1111/j.1365-2133.2007.08236.x ID - Revicki2008 ER - TY - JOUR AU - Revicki, D. A. AU - Willian, M. K. AU - Menter, A. AU - Gordon, K. B. AU - Kimball, A. B. AU - Leonardi, C. L. AU - Langley, R. G. AU - Kimel, M. AU - Okun, M. PY - 2007 DA - 2007// TI - Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis JO - J Dermatolog Treat VL - 18 UR - https://doi.org/10.1080/09546630701646172 DO - 10.1080/09546630701646172 ID - Revicki2007 ER - TY - JOUR AU - Shikiar, R. AU - Heffernan, M. AU - Langley, R. G. AU - Willian, M. K. AU - Okun, M. M. AU - Revicki, D. A. PY - 2007 DA - 2007// TI - Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: patient-reported outcomes from a phase II randomized controlled trial JO - J Dermatolog Treat VL - 18 UR - https://doi.org/10.1080/09546630601121060 DO - 10.1080/09546630601121060 ID - Shikiar2007 ER - TY - JOUR AU - Gordon, K. B. AU - Langley, R. G. AU - Leonardi, C. AU - Toth, D. AU - Menter, M. A. AU - Kang, S. AU - Heffernan, M. AU - Miller, B. AU - Hamlin, R. AU - Lim, L. AU - Zhong, J. AU - Hoffman, R. AU - Okun, M. M. PY - 2006 DA - 2006// TI - Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension study JO - J Am Acad Dermatol VL - 55 UR - https://doi.org/10.1016/j.jaad.2006.05.027 DO - 10.1016/j.jaad.2006.05.027 ID - Gordon2006 ER - TY - JOUR AU - Revicki, D. AU - Hays, R. AU - Cella, D. AU - Sloan, J. PY - 2008 DA - 2008// TI - Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes JO - J Clin Epidemiol VL - 61 UR - https://doi.org/10.1016/j.jclinepi.2007.03.012 DO - 10.1016/j.jclinepi.2007.03.012 ID - Revicki2008 ER - TY - JOUR AU - Wyrwich, K. W. AU - Bullinger, M. AU - Aaronson, N. AU - Hays, R. D. AU - Patrick, D. L. AU - Symonds, T. AU - Sloan, J. A. PY - 2005 DA - 2005// TI - Estimating clinically significant differences in quality of life outcomes JO - Qual Life Res VL - 14 UR - https://doi.org/10.1007/s11136-004-0705-2 DO - 10.1007/s11136-004-0705-2 ID - Wyrwich2005 ER - TY - CHAP AU - Ware, J. E. AU - Keller, S. K. ED - Spilker, B. PY - 1996 DA - 1996// TI - Interpreting general health measures BT - Quality of life and pharmacoeconomics in clinical trials PB - Lippincott-Raven CY - Philadelphia ID - Ware1996 ER - TY - JOUR AU - Menter, A. AU - Tyring, S. K. AU - Gordon, K. AU - Kimball, A. B. AU - Leonardi, C. L. AU - Langley, R. G. AU - Strober, B. E. AU - Kaul, M. AU - Gu, Y. AU - Okun, M. AU - Papp, K. PY - 2008 DA - 2008// TI - Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial JO - J Am Acad Dermatol VL - 58 UR - https://doi.org/10.1016/j.jaad.2007.09.010 DO - 10.1016/j.jaad.2007.09.010 ID - Menter2008 ER - TY - BOOK AU - Ware, J. E. AU - Kosinski, M. AU - Keller, S. D. PY - 2001 DA - 2001// TI - The SF-36 Physical and Mental Health Summary Scales: A Manual for User's of Version 1 PB - QualityMetric Incorporated CY - Lincoln, RI ID - Ware2001 ER - TY - BOOK AU - Ware, J. E. AU - Kosinski, M. AU - Turner-Bowker, D. M. AU - Gandek, B. PY - 2002 DA - 2002// TI - How to Score Version 2 of the SF-12 Health Survey (with a supplement documenting version 1) PB - QualityMetric Incorporated CY - Lincoln, RI ID - Ware2002 ER - TY - STD TI - Medical Expenditures Panel Survey[http://www.meps.ahrq.gov] UR - http://www.meps.ahrq.gov ID - ref26 ER - TY - BOOK AU - Ware, J. E. AU - Kosinski, M. AU - Gandek, B. PY - 2000 DA - 2000// TI - The SF-36 Health Survey: A Manual & Interpretation Guide PB - QualityMetric Incorporated CY - Lincoln, RI ID - Ware2000 ER - TY - JOUR AU - Ellis, C. N. AU - Mordin, M. M. AU - Adler, E. Y. PY - 2003 DA - 2003// TI - Effects of alefacept on health-related quality of life in patients with psoriasis: results from a randomized, placebo-controlled phase II trial JO - Am J Clin Dermatol VL - 4 UR - https://doi.org/10.2165/00128071-200304020-00005 DO - 10.2165/00128071-200304020-00005 ID - Ellis2003 ER - TY - JOUR AU - Heydendael, V. M. AU - de Borgie, C. A. AU - Spuls, P. I. AU - Bossuyt, P. M. AU - Bos, J. D. AU - de Rie, M. A. PY - 2004 DA - 2004// TI - The burden of psoriasis is not determined by disease severity only JO - J Investig Dermatol Symp Proc VL - 9 UR - https://doi.org/10.1111/j.1087-0024.2004.09115.x DO - 10.1111/j.1087-0024.2004.09115.x ID - Heydendael2004 ER - TY - JOUR AU - Esposito, M. AU - Saraceno, R. AU - Giunta, A. AU - Maccarone, M. AU - Chimenti, S. PY - 2006 DA - 2006// TI - An Italian study on psoriasis and depression JO - Dermatology VL - 212 UR - https://doi.org/10.1159/000090652 DO - 10.1159/000090652 ID - Esposito2006 ER - TY - JOUR AU - Krueger, G. G. AU - Ellis, C. N. PY - 2003 DA - 2003// TI - Alefacept therapy produces remission for patients with chronic plaque psoriasis JO - Br J Dermatol VL - 148 UR - https://doi.org/10.1046/j.1365-2133.2003.05239.x DO - 10.1046/j.1365-2133.2003.05239.x ID - Krueger2003 ER - TY - CHAP AU - Menter, A. AU - Okun, M. PY - 2008 DA - 2008// BT - Efficacy and safety of continuous treatment with adalimumab for up to 52 weeks in patients with moderate to severe chronic plaque psoriasis ID - Menter2008 ER - TY - JOUR AU - Simon, G. E. AU - Revicki, D. A. AU - Grothaus, L. AU - Vonkorff, M. PY - 1998 DA - 1998// TI - SF-36 summary scores: are physical and mental health truly distinct? JO - Med Care VL - 36 UR - https://doi.org/10.1097/00005650-199804000-00012 DO - 10.1097/00005650-199804000-00012 ID - Simon1998 ER - TY - JOUR AU - Taft, C. AU - Karlsson, J. AU - Sullivan, M. PY - 2001 DA - 2001// TI - Do SF-36 summary component scores accurately summarize subscale scores? JO - Qual Life Res VL - 10 UR - https://doi.org/10.1023/A:1012552211996 DO - 10.1023/A:1012552211996 ID - Taft2001 ER -